Variety of suitable individuals: CDEC mentioned the uncertainty in the amount of individuals with reasonably severe to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're classified as owning moderate or reasonable condition may have a severe bleeding phenotype, which https://archernrrss.blogchaat.com/35855173/everything-about-hemgenix